342 related articles for article (PubMed ID: 29525514)
1. New approach of ultra-focal brachytherapy for low- and intermediate-risk prostate cancer with custom-linked I-125 seeds: A feasibility study of optimal dose coverage.
Brun T; Bachaud JM; Graff-Cailleaud P; Malavaud B; Portalez D; Popotte C; Aziza R; Lusque A; Filleron T; Ken S
Brachytherapy; 2018; 17(3):544-555. PubMed ID: 29525514
[TBL] [Abstract][Full Text] [Related]
2. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
3. Dosimetry Modeling for Focal Low-Dose-Rate Prostate Brachytherapy.
Al-Qaisieh B; Mason J; Bownes P; Henry A; Dickinson L; Ahmed HU; Emberton M; Langley S
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):787-93. PubMed ID: 25936808
[TBL] [Abstract][Full Text] [Related]
4. Is intraoperative nomogram-based overplanning of prostate implants necessary?
D'Souza WD; Lee HK; Palmer MB; Smith LG; Pollack A
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):462-7. PubMed ID: 12738321
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the MIM Symphony treatment planning system for low-dose-rate- prostate brachytherapy.
Dhanesar SK; Lim TY; Du W; Bruno TL; Frank SJ; Kudchadker RJ
J Appl Clin Med Phys; 2015 Sep; 16(5):62–75. PubMed ID: 26699290
[TBL] [Abstract][Full Text] [Related]
6. Dosimetry modeling for focal high-dose-rate prostate brachytherapy.
Mason J; Al-Qaisieh B; Bownes P; Thwaites D; Henry A
Brachytherapy; 2014; 13(6):611-7. PubMed ID: 25085456
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of intraoperative dosimetry for prostate brachytherapy using registered ultrasound and fluoroscopy.
Lee J; Hobbs RF; Zahurak M; Ng SK; Zhang Z; Burdette EC; DeWeese TL; Song DY
Brachytherapy; 2018; 17(6):858-865. PubMed ID: 30217432
[TBL] [Abstract][Full Text] [Related]
8. [Intraoperative and post-implant dosimetry in patients treated with permanent prostate implant brachytherapy].
Herein A; Ágoston P; Szabó Z; Jorgo K; Markgruber B; Pesznyák C; Polgár C; Major T
Magy Onkol; 2015 Jun; 59(2):148-53. PubMed ID: 26035163
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of clinically relevant dosimetric parameters to contouring uncertainty in postimplant dosimetry of low-dose-rate prostate permanent seed brachytherapy.
Mashouf S; Safigholi H; Merino T; Soliman A; Ravi A; Morton G; Song WY
Brachytherapy; 2016; 15(6):774-779. PubMed ID: 27720310
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the relationship between prescribed dose and dosimetric advantage of real-time intraoperatively built custom-linked seeds in iodine-125 prostate brachytherapy.
Hirose K; Aoki M; Sato M; Akimoto H; Hashimoto Y; Imai A; Kamimura N; Kawaguchi H; Hatayama Y; Fujioka I; Tanaka M; Ohyama C; Takai Y
Radiat Oncol; 2017 Dec; 12(1):192. PubMed ID: 29191234
[TBL] [Abstract][Full Text] [Related]
11. Inverse automated treatment planning with and without individual optimization in interstitial permanent prostate brachytherapy with high- and low-activity 125I.
Pinkawa M; Maurer U; Mulhern A; Gagel B; Block T; Borchers H; Grieger J; Henkel T; Eble M
Strahlenther Onkol; 2003 Jun; 179(6):417-22. PubMed ID: 12789469
[TBL] [Abstract][Full Text] [Related]
12. Multiparametric MRI and post implant CT-based dosimetry after prostate brachytherapy with iodine seeds: The higher the dose to the dominant index lesion, the lower the PSA bounce.
Quivrin M; Loffroy R; Cormier L; Mazoyer F; Bertaut A; Chambade D; Martin E; Maingon P; Walker P; Créhange G
Radiother Oncol; 2015 Nov; 117(2):258-61. PubMed ID: 26324019
[TBL] [Abstract][Full Text] [Related]
13. Refining prostate seed brachytherapy: Comparing high-, intermediate-, and low-activity seeds for I-125 permanent seed prostate brachytherapy.
Delouya G; Bahary P; Carrier JF; Larouche RX; Hervieux Y; Béliveau-Nadeau D; Donath D; Taussky D
Brachytherapy; 2015; 14(3):329-33. PubMed ID: 25630619
[TBL] [Abstract][Full Text] [Related]
14. Loose versus stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plans.
Major T; Agoston P; Fröhlich G; Baricza K; Szabo Z; Jorgo K; Herein A; Polgar C
Phys Med; 2014 Dec; 30(8):909-13. PubMed ID: 25175151
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric evaluation of high-dose-rate interstitial brachytherapy boost treatments for localized prostate cancer.
Fröhlich G; Agoston P; Lövey J; Somogyi A; Fodor J; Polgár C; Major T
Strahlenther Onkol; 2010 Jul; 186(7):388-95. PubMed ID: 20582396
[TBL] [Abstract][Full Text] [Related]
17. Inferring postimplant dose distribution of salvage permanent prostate implant (PPI) after primary PPI on CT images.
Girum KB; Lalande A; Quivrin M; Bessières I; Pierrat N; Martin E; Cormier L; Petitfils A; Cosset JM; Créhange G
Brachytherapy; 2018; 17(6):866-873. PubMed ID: 30217431
[TBL] [Abstract][Full Text] [Related]
18. Comparison of seed loading approaches in prostate brachytherapy.
Butler WM; Merrick GS; Lief JH; Dorsey AT
Med Phys; 2000 Feb; 27(2):381-92. PubMed ID: 10718143
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Med Phys; 2013 Mar; 40(3):031717. PubMed ID: 23464312
[TBL] [Abstract][Full Text] [Related]
20. Establishing implantation uncertainties for focal brachytherapy with I-125 seeds for the treatment of localized prostate cancer.
Polders DL; Steggerda M; van Herk M; Nichol K; Witteveen T; Moonen L; Nijkamp J; van der Heide UA
Acta Oncol; 2015 Jun; 54(6):839-46. PubMed ID: 25591817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
